Head-to-head · WeighScore
Green Cap Health vs Queen RX
The verdict
Queen RX takes it — 66/100 to 65.3/100, but only just.
Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Green Cap Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Green Cap Health | Queen RX |
|---|---|---|
| WeighScore | 65.3/100 | 66/100 |
| Grade | C | C |
| Scorecard rank | #227 | #214 |
| Semaglutide | $79/mo (starting dose, first-month rate, compounded) | $100/mo (quarterly plan, compounded) |
| Tirzepatide | $119/mo (starting dose, compounded) | Not disclosed |
| Coverage | 1 states | 45 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #227 · C
Strengths
- Vertically integrated — it is both the clinical practice and its own 503A Texas compounding pharmacy, a clear supply chain
- Aggressive $79 first-month intro pricing, competitive despite being Texas-only
- Texas patients can consolidate GLP-1, hair, skin, and sexual wellness under one practice
- Phone support published with a Houston area code
- Same-day provider review, faster than 24–48hr competitors
Where it loses points
- Texas only — patients in the other 49 states and DC can't use it
- No tirzepatide — semaglutide only, so those wanting the higher-magnitude option must look elsewhere
- LegitScript certification status not disclosed
- No named medical director — only "doctors, nurse practitioners, and pharmacists"
- FDA compounded-medication disclaimer not visible on the homepage
Graded #214 · C
Strengths
- $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
- Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
- 45-state coverage
Where it loses points
- No LegitScript or PCAB accreditation
- No legal entity name or address disclosed
- No named pharmacy partners
- Not available in KS, LA, MS, NM, WV
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.